These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32679015)

  • 21. Mechanisms and Characteristics of Sulfonylureas and Glinides.
    Lv W; Wang X; Xu Q; Lu W
    Curr Top Med Chem; 2020; 20(1):37-56. PubMed ID: 31884929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.
    Correia S; Carvalho C; Santos MS; Seiça R; Oliveira CR; Moreira PI
    Mini Rev Med Chem; 2008 Nov; 8(13):1343-54. PubMed ID: 18991752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular effects of new non-insulinic anti-diabetes drugs].
    Dieuzeide G; Puchulu F; Sanabria H; Sinay I
    Medicina (B Aires); 2018; 78(3):185-193. PubMed ID: 29940545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of blood glucose-lowering drugs in the light of the UKPDS. United Kingdom Prospective Diabetes Study.
    Monnier L
    Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S14-23. PubMed ID: 11221798
    [No Abstract]   [Full Text] [Related]  

  • 27. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
    Lebovitz HE
    Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes mellitus and its management with medicinal plants: A perspective based on Iranian research.
    Rezaei A; Farzadfard A; Amirahmadi A; Alemi M; Khademi M
    J Ethnopharmacol; 2015 Dec; 175():567-616. PubMed ID: 26283471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increased blood sugar in type 2 diabetes mellitus: what now?].
    Winter T
    Praxis (Bern 1994); 2002 Mar; 91(12):498-502. PubMed ID: 11974431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aamar-e-Advia (shelf-lives) of drugs in Unani system of medicine: A conceptual review.
    Yasmeen A; Sofi G; Khan K
    J Integr Med; 2020 Mar; 18(2):114-124. PubMed ID: 31983657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus.
    Gu X; Huang N; Gu J; Joshi MK; Wang H
    J Ethnopharmacol; 2016 Nov; 192():516-523. PubMed ID: 27616025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Medications for the Treatment of Diabetes.
    Garg SK; Giordano D; Gallo T; Shah VN
    Diabetes Technol Ther; 2017 Feb; 19(S1):S128-S140. PubMed ID: 28192022
    [No Abstract]   [Full Text] [Related]  

  • 35. Beneficial effects resulting from thiazolidinediones for treatment of type 2 diabetes mellitus.
    Bell DS
    Postgrad Med; 2003 May; Spec No():35-44. PubMed ID: 12785130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concept of 'Ihtiraq' in Unani Medicine - A correlation with oxidative stress, and future prospects.
    Kausar F; Yusuf Amin KM; Bashir S; Parvez A; Ahmad P
    J Ethnopharmacol; 2021 Jan; 265():113269. PubMed ID: 32937158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public health approach of Unani medicine to cope and stay safe in hot environmental conditions.
    Khan TN; Itrat M; Ansari TH
    J Basic Clin Physiol Pharmacol; 2021 Mar; 33(3):235-241. PubMed ID: 33711220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
    Singh-Franco D; Robles G; Gazze D
    Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.